McCoy, Rozalina G. https://orcid.org/0000-0002-2289-3183
Van Houten, Holly K.
Dunlay, Shannon M.
Yao, Xiaoxi
Dempsey, Timothy
Noseworthy, Peter A.
Sangaralingham, Lindsey R.
Limper, Andrew H.
Shah, Nilay D.
Article History
Received: 23 December 2020
Accepted: 23 March 2021
First Online: 8 April 2021
Compliance with ethical standards
:
: The authors have no competing interests to declare. In the past 36 months, R.G.M. also received support from an AARP<sup>®</sup> Quality Measure Innovation Grant and the NIDDK (P30DK111024). In the past 36 months, N.D.S. has received research support through Mayo Clinic from the Food and Drug Administration (FDA) to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); the Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); the AHRQ (R01HS025164; R01HS025402; R03HS025517); the National Heart, Lung and Blood Institute of the NIH (R56HL130496; R01HL131535); the National Science Foundation; and the Patient Centered Outcomes Research Institute (PCORI) to develop a Clinical Data Research Network (LHSNet). S.M.D. receives research support from the NIH (R01HL144529, R03HL135225, T32HL07111) and the FDA (U01FD005938). P.A.N. receives funding from NIH (R01AG062436-01A1, R21HL140205, R01HL131535, R01HS25402, R01HL143070) FDA (U01FD05938) and the American Heart Association (18SFRN34230146). A.H.L. receives research support from the NIH (R01HL62150) and the Caerus Foundation and Three Lakes Partners Foundation. X.Y. receives funding from NIH (R01AG062436, R21HL140205, R01HS025402) and FDA (U01FD005938).
: This study was exempted from review by the Mayo Clinic Institutional Review Board, as it involves research on de-identified data.